Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
is under investigation to treat leukemia patients
OS(O)(=O)=O
InChiKey: PHHZKBMVRPULAW-UHFFFAOYSA-N
Rigosertib (250 mg/kg) markedly inhibits tumor growth
Ipragliflozin treatment improved glycaemic control when added to metformin therapy and may be associated with weight loss and reductions in blood pressure compared to placebo
dCBP-1 Catalog No.:M14034-2 is under investigation to treatdCBP 1 is a potent and selective heterobifunctional degrader of p300 CBP based on PROTAC. dCBP 1 is exceptionally potent at killing multiple myeloma cells and ablates oncogenic enhancer activity driving MYC expression. Product information CAS Number: 2484739 25 3 Molecular Weight: 1028. 11 Formula: C51H63F2N11O10 Chemical Name: 3 [7 (difluoromethyl) 6 (1 methyl 1H pyrazol 4 yl) 1,2,3,4 tetrahydroquinolin 1 yl] 1 [1 (1 {[2 (2,6 dioxopiperidin 3 yl) 1,3
US$ 60.00
US$ 76.00
US$ 129.00
US$ 81.32
US$ 99.00
US$ 152.00
US$ 272.50